Delayed Tc-99m citrate scintigraphy in the evaluation of palpable breast masses

Clinical Nuclear Medicine

Volumn 24, Issue 5, 1999, Pages 309-313

  Mondal, Anupam ^a   Sharma, Rajnish ^a   Chakravarty, K L ^a   Mishra, Pushpa ^a   Sahay, Kavita ^a   Bhatnagar, Aseem ^a   Gupta, Ashwani ^a   Sawroop, K ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

24 Hour delayed scanning; Breast Masses; Scintimammography; Tc 99m citrate; Uptake and outflow patterns

Indexed keywords

CITRATE TECHNETIUM TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; SCINTIMAMMOGRAPHY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; BIOPSY; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CITRATES; FEMALE; HUMANS; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PALPATION; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 0032948201     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199905000-00002     Document Type: Article

References (24)

1. Bland KI, Copeland EM III: Breast. In: Schwartz SI, Shires GT, Spence FD, eds. Principles of Surgery. New York: McGraw Hill, 1994, pp 531-95.
2. Wal AJ: Screening for breast cancer. In: Cameron JL, ed. Current Surgical Therapy. St. Louis, MO: Mosby Year Book, 1995, pp 536-44.
3. Kopans DB: Early breast cancer detection using technique other than mammography. AJR 143:465, 1984.
4. Homer MJ: Nonpalpable breast abnormalities: A realistic view of the accuracy of mammography in detecting malignancy. Radiology 153:831, 1984.
5. Basett LW, Liu TH, Giuliano AE, et al: The prevalence of carcinoma in palpable versus impalpable, mammographically detected lesion. AJR 157:21, 1991.
6. Kopans DB: The positive predictive value of mammography: Preliminary results. Eur J Nucl Med 22:742, 1995.
7. Waxman AD, Rananna L, Mimsei LD, et al: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34:18, 1993.
8. Aktobin C, Bayhan H, Kir M: Clinical experience with the Tc-99m MIBI imaging in patients with malignant tumors, preliminary results and comparison with T1-201. Clin Nucl Med 17:171, 1992.
9. Khalkhali I, Mena I, Diggles L: Review of imaging techniques for diagnosis of breast cancer: A new role of prone scintigraphy mammography using Tc-99m sestamibi. Cur J Nucl Med 21:357, 1994.
10. Adalet I, Demirkol M, Cantez, et al: Tc-99m tetrofosmin scintigraphy in the evaluation of palpable breast masses. Can J Surg 24:50, 1988.
11. Rambaldi PF, Mansi L, Procacunii et al: Breast cancer detection with Tc-tetrofosmin. Clin Nucl Med 20:702, 1995.
12. Gati LJ, Wiebe LT, Tse JW, et al: Comparative studies of radiocitrates in oncological models. Nucl Med Biol 13:253, 1986.
13. Ercan MT, Aras T, Aldalir AMS: Scintigraphic visualization of acute pancreatitis in cats with Tc-99m citrate. Nucl Med Commun 14:798, 1993.
14. Ercan MT, Aras T, Unlinen E, et al: Tc-99m citrate versus Ga-67 citrate for scintigraphic visualization of inflammatory lesion. Nucl Med Biol 20:881, 1997.
15. Chauhan UPS, Mishra P, Chuttani K, et al: A kit for instant preparation of Tc-99m citrate for tumour and inflammation. Nucl Med Comm 17:979, 1996.
16. Sharma R, Mondal A, Bhatnagar A: Differentiation of malignant and degenerative bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy. Clin Nucl Med 23:758, 1998.
17. Mam BD, Givelliano AE, Basset LW, et al: Delayed diagnosis of breast cancer as a result of normal mammography. Arch Surg 118:23, 1983.
18. Bush PE, Grace MG, Lees AN, et al: False negative mammogram causing delay in breast cancer diagnosis. N Engl J Med 299:201, 1978.
19. Niloff PH, Shiener NM: False negative mammogram. Clin J Surg 50, 1988.
20. Suga K, Nishiganchi K, Fugita T, et al: Difference of Thallium 201 VX2 tumors and inflammatory lesions in rabbits. Kaku-Igaku, 31:151, 1994.
21. Khalkhali I, Cutrone J, Mena I, et al: Technetium 99m sestamibi scintimammography of breast lesions: Clinical and pathological follow up. J Nucl Med 36:1784, 1995.
22. Kao CH, Wang SJ, Liu TJ: The use of Tc-99m MIBI breast scintigraphy to evaluate palpable breast mass. Eur J Nucl Med 21:432, 1994.
23. Cimetan M, Volpe R, Canadian E, et al: The use of T1-201 in preoperative detection of breast case: An adjuvant to mammography and ultrasonography. Eur J Nucl Med 10:1110, 1995.
24. Adalet I, Demirkol MO, Cantez S, et al: 99m-Tc tetrofosmin scintigraphy in the evaluation of palpable breast masses. Nucl Med Commun 18:118, 1997.